PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications
Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry is currently used in pathology for the assessment of melanocytic neoplasms; however, knowledge of its expression patterns in soft tissue tumors is limited. PRAME immunohistochemistry (clone QR005) was assessed on whole tissue...
Uloženo v:
| Vydáno v: | Virchows Archiv : an international journal of pathology Ročník 483; číslo 2; s. 145 - 156 |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.08.2023
Springer Nature B.V |
| Témata: | |
| ISSN: | 0945-6317, 1432-2307, 1432-2307 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry is currently used in pathology for the assessment of melanocytic neoplasms; however, knowledge of its expression patterns in soft tissue tumors is limited. PRAME immunohistochemistry (clone QR005) was assessed on whole tissue sections of 350 soft-tissue tumors and mimics (> 50 histotypes). PRAME immunoreactivity was evaluated as follows: 0 “negative” (0% positive cells); 1+ (1–25% positive cells); 2+ (26–50% positive cells); 3+ (51–75% positive cells), and 4+ “diffuse” (> 75% positive cells). PRAME was expressed in 111 lesions (0 benign, 6 intermediate malignancy, and 105 malignant), including fibrosarcomatous dermatofibrosarcoma protuberans (2/4, 0 diffuse),
NTRK
-rearranged spindle cell neoplasm (2/4, 0 diffuse), atypical fibroxanthoma (1/7, 0 diffuse), Kaposi sarcoma (1/5, 0 diffuse), myxoid liposarcoma (11/11, 9 diffuse), synovial sarcoma (11/11, 6 diffuse), intimal sarcoma (7/7, 5 diffuse), biphenotypic sinonasal sarcoma (3/3, 1 diffuse), angiosarcoma (10/15, 6 diffuse), malignant peripheral nerve sheath tumor (9/12, 4 diffuse), pleomorphic rhabdomyosarcoma (2/3, 2 diffuse), alveolar rhabdomyosarcoma (2/6, 0 diffuse), embryonal rhabdomyosarcoma (7/7, 4 diffuse), undifferentiated pleomorphic sarcoma (2/12, 1 diffuse), leiomyosarcoma (2/15, 1 diffuse), clear cell sarcoma of soft tissue (1/10, 0 diffuse), low-grade fibromyxoid sarcoma (1/5, 0 diffuse), Ewing sarcoma (2/10, 1 diffuse),
CIC
-rearranged sarcoma (8/8, 4 diffuse),
BCOR
-sarcoma (2/5, 1 diffuse), melanoma (20/20, 14 diffuse), and thoracic SMARCA4-deficient undifferentiated tumor (5/5, all diffuse). All tested cases of spindle cell lipoma, dedifferentiated/pleomorphic liposarcoma, dermatofibrosarcoma protuberans, solitary fibrous tumor, inflammatory myofibroblastic tumor, myxoinflammatory fibroblastic sarcoma, nodular fasciitis, myxofibrosarcoma, epithelioid hemangioendothelioma, atypical vascular lesion, hemangioma, lymphangioma, vascular malformation, papillary endothelial hyperplasia, GIST, gastrointestinal clear-cell sarcoma, malignant melanotic nerve sheath tumor, neurofibroma, schwannoma, granular cell tumor, alveolar soft part sarcoma, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, myoepithelioma, ossifying fibromyxoid tumor, angiomatoid fibrous histiocytoma, PEComa, dermatofibroma, pleomorphic dermal sarcoma, and chordoma were negative. PRAME shows imperfect specificity in soft-tissue pathology but may serve as a diagnostic adjunct in selected differential diagnoses that show contrasting expression patterns. |
|---|---|
| AbstractList | Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry is currently used in pathology for the assessment of melanocytic neoplasms; however, knowledge of its expression patterns in soft tissue tumors is limited. PRAME immunohistochemistry (clone QR005) was assessed on whole tissue sections of 350 soft-tissue tumors and mimics (> 50 histotypes). PRAME immunoreactivity was evaluated as follows: 0 "negative" (0% positive cells); 1+ (1-25% positive cells); 2+ (26-50% positive cells); 3+ (51-75% positive cells), and 4+ "diffuse" (> 75% positive cells). PRAME was expressed in 111 lesions (0 benign, 6 intermediate malignancy, and 105 malignant), including fibrosarcomatous dermatofibrosarcoma protuberans (2/4, 0 diffuse), NTRK-rearranged spindle cell neoplasm (2/4, 0 diffuse), atypical fibroxanthoma (1/7, 0 diffuse), Kaposi sarcoma (1/5, 0 diffuse), myxoid liposarcoma (11/11, 9 diffuse), synovial sarcoma (11/11, 6 diffuse), intimal sarcoma (7/7, 5 diffuse), biphenotypic sinonasal sarcoma (3/3, 1 diffuse), angiosarcoma (10/15, 6 diffuse), malignant peripheral nerve sheath tumor (9/12, 4 diffuse), pleomorphic rhabdomyosarcoma (2/3, 2 diffuse), alveolar rhabdomyosarcoma (2/6, 0 diffuse), embryonal rhabdomyosarcoma (7/7, 4 diffuse), undifferentiated pleomorphic sarcoma (2/12, 1 diffuse), leiomyosarcoma (2/15, 1 diffuse), clear cell sarcoma of soft tissue (1/10, 0 diffuse), low-grade fibromyxoid sarcoma (1/5, 0 diffuse), Ewing sarcoma (2/10, 1 diffuse), CIC-rearranged sarcoma (8/8, 4 diffuse), BCOR-sarcoma (2/5, 1 diffuse), melanoma (20/20, 14 diffuse), and thoracic SMARCA4-deficient undifferentiated tumor (5/5, all diffuse). All tested cases of spindle cell lipoma, dedifferentiated/pleomorphic liposarcoma, dermatofibrosarcoma protuberans, solitary fibrous tumor, inflammatory myofibroblastic tumor, myxoinflammatory fibroblastic sarcoma, nodular fasciitis, myxofibrosarcoma, epithelioid hemangioendothelioma, atypical vascular lesion, hemangioma, lymphangioma, vascular malformation, papillary endothelial hyperplasia, GIST, gastrointestinal clear-cell sarcoma, malignant melanotic nerve sheath tumor, neurofibroma, schwannoma, granular cell tumor, alveolar soft part sarcoma, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, myoepithelioma, ossifying fibromyxoid tumor, angiomatoid fibrous histiocytoma, PEComa, dermatofibroma, pleomorphic dermal sarcoma, and chordoma were negative. PRAME shows imperfect specificity in soft-tissue pathology but may serve as a diagnostic adjunct in selected differential diagnoses that show contrasting expression patterns. Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry is currently used in pathology for the assessment of melanocytic neoplasms; however, knowledge of its expression patterns in soft tissue tumors is limited. PRAME immunohistochemistry (clone QR005) was assessed on whole tissue sections of 350 soft-tissue tumors and mimics (> 50 histotypes). PRAME immunoreactivity was evaluated as follows: 0 “negative” (0% positive cells); 1+ (1–25% positive cells); 2+ (26–50% positive cells); 3+ (51–75% positive cells), and 4+ “diffuse” (> 75% positive cells). PRAME was expressed in 111 lesions (0 benign, 6 intermediate malignancy, and 105 malignant), including fibrosarcomatous dermatofibrosarcoma protuberans (2/4, 0 diffuse), NTRK -rearranged spindle cell neoplasm (2/4, 0 diffuse), atypical fibroxanthoma (1/7, 0 diffuse), Kaposi sarcoma (1/5, 0 diffuse), myxoid liposarcoma (11/11, 9 diffuse), synovial sarcoma (11/11, 6 diffuse), intimal sarcoma (7/7, 5 diffuse), biphenotypic sinonasal sarcoma (3/3, 1 diffuse), angiosarcoma (10/15, 6 diffuse), malignant peripheral nerve sheath tumor (9/12, 4 diffuse), pleomorphic rhabdomyosarcoma (2/3, 2 diffuse), alveolar rhabdomyosarcoma (2/6, 0 diffuse), embryonal rhabdomyosarcoma (7/7, 4 diffuse), undifferentiated pleomorphic sarcoma (2/12, 1 diffuse), leiomyosarcoma (2/15, 1 diffuse), clear cell sarcoma of soft tissue (1/10, 0 diffuse), low-grade fibromyxoid sarcoma (1/5, 0 diffuse), Ewing sarcoma (2/10, 1 diffuse), CIC -rearranged sarcoma (8/8, 4 diffuse), BCOR -sarcoma (2/5, 1 diffuse), melanoma (20/20, 14 diffuse), and thoracic SMARCA4-deficient undifferentiated tumor (5/5, all diffuse). All tested cases of spindle cell lipoma, dedifferentiated/pleomorphic liposarcoma, dermatofibrosarcoma protuberans, solitary fibrous tumor, inflammatory myofibroblastic tumor, myxoinflammatory fibroblastic sarcoma, nodular fasciitis, myxofibrosarcoma, epithelioid hemangioendothelioma, atypical vascular lesion, hemangioma, lymphangioma, vascular malformation, papillary endothelial hyperplasia, GIST, gastrointestinal clear-cell sarcoma, malignant melanotic nerve sheath tumor, neurofibroma, schwannoma, granular cell tumor, alveolar soft part sarcoma, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, myoepithelioma, ossifying fibromyxoid tumor, angiomatoid fibrous histiocytoma, PEComa, dermatofibroma, pleomorphic dermal sarcoma, and chordoma were negative. PRAME shows imperfect specificity in soft-tissue pathology but may serve as a diagnostic adjunct in selected differential diagnoses that show contrasting expression patterns. Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry is currently used in pathology for the assessment of melanocytic neoplasms; however, knowledge of its expression patterns in soft tissue tumors is limited. PRAME immunohistochemistry (clone QR005) was assessed on whole tissue sections of 350 soft-tissue tumors and mimics (> 50 histotypes). PRAME immunoreactivity was evaluated as follows: 0 "negative" (0% positive cells); 1+ (1-25% positive cells); 2+ (26-50% positive cells); 3+ (51-75% positive cells), and 4+ "diffuse" (> 75% positive cells). PRAME was expressed in 111 lesions (0 benign, 6 intermediate malignancy, and 105 malignant), including fibrosarcomatous dermatofibrosarcoma protuberans (2/4, 0 diffuse), NTRK-rearranged spindle cell neoplasm (2/4, 0 diffuse), atypical fibroxanthoma (1/7, 0 diffuse), Kaposi sarcoma (1/5, 0 diffuse), myxoid liposarcoma (11/11, 9 diffuse), synovial sarcoma (11/11, 6 diffuse), intimal sarcoma (7/7, 5 diffuse), biphenotypic sinonasal sarcoma (3/3, 1 diffuse), angiosarcoma (10/15, 6 diffuse), malignant peripheral nerve sheath tumor (9/12, 4 diffuse), pleomorphic rhabdomyosarcoma (2/3, 2 diffuse), alveolar rhabdomyosarcoma (2/6, 0 diffuse), embryonal rhabdomyosarcoma (7/7, 4 diffuse), undifferentiated pleomorphic sarcoma (2/12, 1 diffuse), leiomyosarcoma (2/15, 1 diffuse), clear cell sarcoma of soft tissue (1/10, 0 diffuse), low-grade fibromyxoid sarcoma (1/5, 0 diffuse), Ewing sarcoma (2/10, 1 diffuse), CIC-rearranged sarcoma (8/8, 4 diffuse), BCOR-sarcoma (2/5, 1 diffuse), melanoma (20/20, 14 diffuse), and thoracic SMARCA4-deficient undifferentiated tumor (5/5, all diffuse). All tested cases of spindle cell lipoma, dedifferentiated/pleomorphic liposarcoma, dermatofibrosarcoma protuberans, solitary fibrous tumor, inflammatory myofibroblastic tumor, myxoinflammatory fibroblastic sarcoma, nodular fasciitis, myxofibrosarcoma, epithelioid hemangioendothelioma, atypical vascular lesion, hemangioma, lymphangioma, vascular malformation, papillary endothelial hyperplasia, GIST, gastrointestinal clear-cell sarcoma, malignant melanotic nerve sheath tumor, neurofibroma, schwannoma, granular cell tumor, alveolar soft part sarcoma, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, myoepithelioma, ossifying fibromyxoid tumor, angiomatoid fibrous histiocytoma, PEComa, dermatofibroma, pleomorphic dermal sarcoma, and chordoma were negative. PRAME shows imperfect specificity in soft-tissue pathology but may serve as a diagnostic adjunct in selected differential diagnoses that show contrasting expression patterns.Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry is currently used in pathology for the assessment of melanocytic neoplasms; however, knowledge of its expression patterns in soft tissue tumors is limited. PRAME immunohistochemistry (clone QR005) was assessed on whole tissue sections of 350 soft-tissue tumors and mimics (> 50 histotypes). PRAME immunoreactivity was evaluated as follows: 0 "negative" (0% positive cells); 1+ (1-25% positive cells); 2+ (26-50% positive cells); 3+ (51-75% positive cells), and 4+ "diffuse" (> 75% positive cells). PRAME was expressed in 111 lesions (0 benign, 6 intermediate malignancy, and 105 malignant), including fibrosarcomatous dermatofibrosarcoma protuberans (2/4, 0 diffuse), NTRK-rearranged spindle cell neoplasm (2/4, 0 diffuse), atypical fibroxanthoma (1/7, 0 diffuse), Kaposi sarcoma (1/5, 0 diffuse), myxoid liposarcoma (11/11, 9 diffuse), synovial sarcoma (11/11, 6 diffuse), intimal sarcoma (7/7, 5 diffuse), biphenotypic sinonasal sarcoma (3/3, 1 diffuse), angiosarcoma (10/15, 6 diffuse), malignant peripheral nerve sheath tumor (9/12, 4 diffuse), pleomorphic rhabdomyosarcoma (2/3, 2 diffuse), alveolar rhabdomyosarcoma (2/6, 0 diffuse), embryonal rhabdomyosarcoma (7/7, 4 diffuse), undifferentiated pleomorphic sarcoma (2/12, 1 diffuse), leiomyosarcoma (2/15, 1 diffuse), clear cell sarcoma of soft tissue (1/10, 0 diffuse), low-grade fibromyxoid sarcoma (1/5, 0 diffuse), Ewing sarcoma (2/10, 1 diffuse), CIC-rearranged sarcoma (8/8, 4 diffuse), BCOR-sarcoma (2/5, 1 diffuse), melanoma (20/20, 14 diffuse), and thoracic SMARCA4-deficient undifferentiated tumor (5/5, all diffuse). All tested cases of spindle cell lipoma, dedifferentiated/pleomorphic liposarcoma, dermatofibrosarcoma protuberans, solitary fibrous tumor, inflammatory myofibroblastic tumor, myxoinflammatory fibroblastic sarcoma, nodular fasciitis, myxofibrosarcoma, epithelioid hemangioendothelioma, atypical vascular lesion, hemangioma, lymphangioma, vascular malformation, papillary endothelial hyperplasia, GIST, gastrointestinal clear-cell sarcoma, malignant melanotic nerve sheath tumor, neurofibroma, schwannoma, granular cell tumor, alveolar soft part sarcoma, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, myoepithelioma, ossifying fibromyxoid tumor, angiomatoid fibrous histiocytoma, PEComa, dermatofibroma, pleomorphic dermal sarcoma, and chordoma were negative. PRAME shows imperfect specificity in soft-tissue pathology but may serve as a diagnostic adjunct in selected differential diagnoses that show contrasting expression patterns. |
| Author | Beltzung, Fanny Vanhersecke, Lucile Coindre, Jean-Michel Le Loarer, François Velasco, Valérie Vergier, Béatrice Perret, Raul Cammareri, Chloé Michal, Michael |
| Author_xml | – sequence: 1 givenname: Chloé surname: Cammareri fullname: Cammareri, Chloé organization: University of Bordeaux, Department of Biopathology, Institut Bergonié – sequence: 2 givenname: Fanny surname: Beltzung fullname: Beltzung, Fanny organization: Department of Pathology, Bordeaux University Hospital – sequence: 3 givenname: Michael surname: Michal fullname: Michal, Michael organization: Department of Pathology, Faculty of Medicine in Plzen, Charles University, Bioptical Laboratory Ltd – sequence: 4 givenname: Lucile surname: Vanhersecke fullname: Vanhersecke, Lucile organization: Department of Biopathology, Institut Bergonié – sequence: 5 givenname: Jean-Michel surname: Coindre fullname: Coindre, Jean-Michel organization: University of Bordeaux, Department of Biopathology, Institut Bergonié – sequence: 6 givenname: Valérie surname: Velasco fullname: Velasco, Valérie organization: Department of Biopathology, Institut Bergonié – sequence: 7 givenname: François surname: Le Loarer fullname: Le Loarer, François organization: University of Bordeaux, Department of Biopathology, Institut Bergonié, INSERM U1218, ACTION, Institut Bergonié – sequence: 8 givenname: Béatrice surname: Vergier fullname: Vergier, Béatrice organization: University of Bordeaux, Department of Pathology, Bordeaux University Hospital – sequence: 9 givenname: Raul orcidid: 0000-0003-2698-0249 surname: Perret fullname: Perret, Raul email: r.perret@bordeaux.unicancer.fr organization: Department of Biopathology, Institut Bergonié, INSERM U1218, ACTION, Institut Bergonié |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37477762$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc1u1DAUhS1URKeFF2CBLLFhE7ixHTthV1WlRSoCIVhHHseZcZXYwdde5Il4TTydAlIXXVh34e_cn3POyIkP3hLyuob3NYD6gACCtRUwXgGXICv5jGxqwVnFOKgTsoFONJXktTolZ4h3AKxua_mCnHIllFKSbcjvb98vvlxRN8_Zh73DFMzezqXGlTpPMYyJJoeYLU15DhGp9gOd3ewMfqSaYsrDSsNIeQPUaLRI9263n8pLzu-oS1iaLzaO1iSKizVudMallW5zoktI1ienp2mlGe2YJzo4vfMBkzNUL8vkjE4ueHxJno96QvvqoZ6Tn5-uflzeVLdfrz9fXtxWhqsmVa3hDLZCG2EakBKE0eVSYRvGFDDQrdyOdpStVqx86cF0o-aiU7o2jZDdwM_Ju2PfJYZf2WLqixnGTpP2NmTsWStqKM0aWdC3j9C7kKMv2x2oFmrWtU2h3jxQeTvboV-im3Vc-78RFIAdARMDYrTjP6SG_pBzf8y5Lzn39zn3h9ntI1Hx9N6pFLWbnpbyoxTLHL-z8f_aT6j-AOSpvwg |
| CitedBy_id | crossref_primary_10_1111_cup_14824 crossref_primary_10_1038_s41388_025_03547_1 crossref_primary_10_1016_j_modpat_2025_100879 crossref_primary_10_1093_ajcp_aqaf084 crossref_primary_10_3390_ijms242115881 crossref_primary_10_3390_ijms25031582 crossref_primary_10_3390_ijtm3030024 crossref_primary_10_1016_j_semdp_2025_150937 crossref_primary_10_3390_diagnostics13243636 crossref_primary_10_1038_s41598_024_74556_5 crossref_primary_10_1016_j_path_2025_05_002 crossref_primary_10_1111_cup_14806 crossref_primary_10_1177_10668969241271902 crossref_primary_10_1016_j_anndiagpath_2025_152497 |
| Cites_doi | 10.1002/gcc.22254 10.1002/gcc.20827 10.1111/his.14312 10.1111/cup.14000 10.1001/jamaophthalmol.2017.0729 10.1016/j.jtho.2016.08.1206 10.1182/blood-2008-07-170282 10.1111/cup.13876 10.1111/his.14814 10.3389/fonc.2021.675296 10.1097/pas.0000000000001944 10.3390/cancers12123612 10.1097/pas.0000000000001878 10.1177/10668969211012085 10.1016/j.path.2021.01.001 10.1097/PAS.0000000000001645 10.1016/j.humpath.2016.12.006 10.1097/dad.0000000000002208 10.1097/pas.0000000000001393 10.1016/j.cell.2005.07.003 10.3390/cancers13153864 10.1111/his.14797 10.1097/dad.0000000000001885 10.1111/cup.13812 10.1111/cup.14163 10.1002/cjp2.16 10.1016/s1074-7613(00)80426-4 10.1136/esmoopen-2016-000068 10.1093/jnen/nlaa125 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7T5 7T7 7TM 7TO 7U7 7U9 7X7 7XB 88A 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s00428-023-03606-6 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Database ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Biological Science Database ProQuest Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts Toxicology Abstracts ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest Central Student MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1432-2307 |
| EndPage | 156 |
| ExternalDocumentID | 37477762 10_1007_s00428_023_03606_6 |
| Genre | Journal Article |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 04C 06C 06D 0R~ 0VY 1N0 2.D 203 28- 29Q 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 78A 7RV 7X7 88A 88E 8AO 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEUYN AEVLU AEXYK AFBBN AFEXP AFFNX AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBLON EBS EIHBH EIOEI EJD EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LK8 LLZTM M0L M1P M4Y M7P MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI RNS RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW X7M YLTOR Z45 Z7U Z81 Z82 Z87 Z8O Z8U Z8V Z91 ZGI ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7T5 7T7 7TM 7TO 7U7 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c375t-8c320b4ac4c506604ca4774e5227020a86bfef68a724caadc9fa3497a1c5469d3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 16 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001034307500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0945-6317 1432-2307 |
| IngestDate | Fri Sep 05 12:24:40 EDT 2025 Wed Nov 05 02:25:57 EST 2025 Thu Apr 03 07:10:12 EDT 2025 Tue Nov 18 21:49:38 EST 2025 Sat Nov 29 04:14:04 EST 2025 Fri Feb 21 02:43:25 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Immunohistochemistry Sarcoma Immunotherapy Melanoma PRAME Soft tissue Differential diagnosis |
| Language | English |
| License | 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c375t-8c320b4ac4c506604ca4774e5227020a86bfef68a724caadc9fa3497a1c5469d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-2698-0249 |
| PMID | 37477762 |
| PQID | 2848012985 |
| PQPubID | 54092 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_2841022756 proquest_journals_2848012985 pubmed_primary_37477762 crossref_primary_10_1007_s00428_023_03606_6 crossref_citationtrail_10_1007_s00428_023_03606_6 springer_journals_10_1007_s00428_023_03606_6 |
| PublicationCentury | 2000 |
| PublicationDate | 20230800 2023-08-00 2023-Aug 20230801 |
| PublicationDateYYYYMMDD | 2023-08-01 |
| PublicationDate_xml | – month: 8 year: 2023 text: 20230800 |
| PublicationDecade | 2020 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationSubtitle | European Journal of Pathology |
| PublicationTitle | Virchows Archiv : an international journal of pathology |
| PublicationTitleAbbrev | Virchows Arch |
| PublicationTitleAlternate | Virchows Arch |
| PublicationYear | 2023 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | Albertsmeier, Altendorf-Hofmann, Lindner (CR24) 2020; 12 Santandrea, Valli, Zanetti (CR12) 2022; 46 Gradecki, Valdes-Rodriguez, Wick, Gru (CR7) 2021; 78 Raghavan, Wang, Toland (CR14) 2020; 47 Iura, Kohashi, Hotokebuchi (CR30) 2015; 1 Gradecki, Slingluff, Gru (CR11) 2021; 48 Lezcano, Müller, Frosina (CR27) 2021; 29 Googe, Flanigan, Miedema (CR16) 2021; 43 Gerami, Benton, Zhao (CR19) 2022; 44 Pujol, De Pas, Rittmeyer (CR5) 2016; 11 Wang, Zehir, Sadowska (CR28) 2015; 54 Agaimy, Stoehr, Hornung (CR20) 2021; 45 Lezcano, Jungbluth, Busam (CR10) 2021; 14 Iura, Maekawa, Kohashi (CR26) 2017; 61 Chen, Zhang, Qiu, Ke, Chen, Chen (CR15) 2023; 82 Epping, Wang, Edel, Carlée, Hernandez, Bernards (CR2) 2005; 122 Kaczorowski, Chłopek, Kruczak, Ryś, Lasota, Miettinen (CR13) 2022; 46 Lezcano, Pulitzer, Moy, Hollmann, Jungbluth, Busam (CR9) 2020; 44 Hrycaj, Szczepanski, Zhao (CR25) 2022; 81 Ferrara, Argenziano (CR17) 2021; 11 Gutzmer, Rivoltini, Levchenko (CR4) 2016; 1 (CR23) 2020 Guo, Zhang, Chang, Singer, Maki, Antonescu (CR29) 2011; 50 Alomari, Tharp, Umphress, Kowal (CR8) 2021; 48 Ikeda, Lethé, Lehmann (CR1) 1997; 6 Oehler, Guthrie, Cummings (CR3) 2009; 114 Cesinaro, Piana, Paganelli, Pedroni, Santandrea, Maiorana (CR22) 2022; 49 Cadwell, Yuksek, Hirbe (CR21) 2021; 80 Gezgin, Luk, Cao (CR6) 2017; 135 Gassenmaier, Hahn, Metzler (CR18) 2021; 13 AK Alomari (3606_CR8) 2021; 48 AM Cesinaro (3606_CR22) 2022; 49 CR Cadwell (3606_CR21) 2021; 80 G Santandrea (3606_CR12) 2022; 46 YP Chen (3606_CR15) 2023; 82 C Lezcano (3606_CR27) 2021; 29 G Gezgin (3606_CR6) 2017; 135 A Agaimy (3606_CR20) 2021; 45 M Gassenmaier (3606_CR18) 2021; 13 L Wang (3606_CR28) 2015; 54 C Lezcano (3606_CR9) 2020; 44 SE Gradecki (3606_CR11) 2021; 48 K Iura (3606_CR30) 2015; 1 SE Gradecki (3606_CR7) 2021; 78 H Ikeda (3606_CR1) 1997; 6 PB Googe (3606_CR16) 2021; 43 VG Oehler (3606_CR3) 2009; 114 P Gerami (3606_CR19) 2022; 44 G Ferrara (3606_CR17) 2021; 11 MT Epping (3606_CR2) 2005; 122 R Gutzmer (3606_CR4) 2016; 1 K Iura (3606_CR26) 2017; 61 C Lezcano (3606_CR10) 2021; 14 WHO Classification of Tumours editorial board (3606_CR23) 2020 T Guo (3606_CR29) 2011; 50 M Kaczorowski (3606_CR13) 2022; 46 SS Raghavan (3606_CR14) 2020; 47 M Albertsmeier (3606_CR24) 2020; 12 JL Pujol (3606_CR5) 2016; 11 SM Hrycaj (3606_CR25) 2022; 81 |
| References_xml | – volume: 54 start-page: 463 year: 2015 end-page: 471 ident: CR28 article-title: Consistent copy number changes and recurrent PRKAR1A mutations distinguish melanotic schwannomas from melanomas: SNP-array and next generation sequencing analysis publication-title: Genes Chromosom Cancer doi: 10.1002/gcc.22254 – volume: 50 start-page: 25 year: 2011 end-page: 33 ident: CR29 article-title: Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions publication-title: Genes Chromosom Cancer doi: 10.1002/gcc.20827 – volume: 78 start-page: 1000 year: 2021 end-page: 1008 ident: CR7 article-title: PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna publication-title: Histopathology doi: 10.1111/his.14312 – volume: 48 start-page: 1115 year: 2021 end-page: 1123 ident: CR8 article-title: The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors publication-title: J Cutan Pathol doi: 10.1111/cup.14000 – volume: 135 start-page: 541 year: 2017 end-page: 549 ident: CR6 article-title: PRAME as a potential target for immunotherapy in metastatic uveal melanoma publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2017.0729 – volume: 11 start-page: 2208 year: 2016 end-page: 2217 ident: CR5 article-title: Safety and immunogenicity of the PRAME cancer immunotherapeutic in patients with resected non-small cell lung cancer: a phase I dose escalation study publication-title: J Thorac Oncol doi: 10.1016/j.jtho.2016.08.1206 – volume: 114 start-page: 3299 year: 2009 end-page: 3308 ident: CR3 article-title: The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells publication-title: Blood doi: 10.1182/blood-2008-07-170282 – volume: 48 start-page: 479 year: 2021 end-page: 485 ident: CR11 article-title: PRAME expression in 155 cases of metastatic melanoma publication-title: J Cutan Pathol doi: 10.1111/cup.13876 – volume: 82 start-page: 285 year: 2023 end-page: 295 ident: CR15 article-title: PRAME is a useful marker for the differential diagnosis of melanocytic tumours and histological mimics publication-title: Histopathology doi: 10.1111/his.14814 – volume: 11 start-page: 675296 year: 2021 ident: CR17 article-title: The WHO 2018 classification of cutaneous melanocytic neoplasms: suggestions from routine practice publication-title: Front Oncol doi: 10.3389/fonc.2021.675296 – volume: 46 start-page: 1467 year: 2022 end-page: 1476 ident: CR13 article-title: PRAME expression in cancer. a systematic immunohistochemical study of >5800 epithelial and nonepithelial tumors publication-title: Am J Surg Pathol doi: 10.1097/pas.0000000000001944 – volume: 12 start-page: 3612 year: 2020 ident: CR24 article-title: Cancer testis antigens and immunotherapy: expression of PRAME is associated with prognosis in soft tissue sarcoma publication-title: Cancers doi: 10.3390/cancers12123612 – volume: 46 start-page: 579 year: 2022 end-page: 590 ident: CR12 article-title: Comparative analysis of PRAME expression in 127 acral and nail melanocytic lesions publication-title: Am J Surg Pathol doi: 10.1097/pas.0000000000001878 – volume: 29 start-page: 826 year: 2021 end-page: 835 ident: CR27 article-title: Immunohistochemical detection of cancer-testis antigen PRAME publication-title: Int J Surg Pathol doi: 10.1177/10668969211012085 – volume: 14 start-page: 165 year: 2021 end-page: 175 ident: CR10 article-title: PRAME immunohistochemistry as an ancillary test for the assessment of melanocytic lesions publication-title: Surg Pathol Clin doi: 10.1016/j.path.2021.01.001 – volume: 45 start-page: 240 year: 2021 end-page: 254 ident: CR20 article-title: Dedifferentiated and undifferentiated melanomas: report of 35 new cases with literature review and proposal of diagnostic criteria publication-title: Am J Surg Pathol doi: 10.1097/PAS.0000000000001645 – year: 2020 ident: CR23 publication-title: Soft tissue and bone tumours 5th edn – volume: 61 start-page: 130 year: 2017 end-page: 139 ident: CR26 article-title: Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1 publication-title: Hum Pathol doi: 10.1016/j.humpath.2016.12.006 – volume: 44 start-page: 575 year: 2022 end-page: 580 ident: CR19 article-title: PRAME expression correlates with genomic aberration and malignant diagnosis of spitzoid melanocytic neoplasms publication-title: Am J Dermatopathol doi: 10.1097/dad.0000000000002208 – volume: 44 start-page: 503 year: 2020 end-page: 508 ident: CR9 article-title: Immunohistochemistry for PRAME in the distinction of nodal nevi from metastatic melanoma publication-title: Am J Surg Pathol doi: 10.1097/pas.0000000000001393 – volume: 122 start-page: 835 year: 2005 end-page: 847 ident: CR2 article-title: The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling publication-title: Cell doi: 10.1016/j.cell.2005.07.003 – volume: 13 start-page: 3864 year: 2021 ident: CR18 article-title: Diffuse PRAME expression is highly specific for thin melanomas in the distinction from severely dysplastic nevi but does not distinguish metastasizing from non-metastasizing thin melanomas publication-title: Cancers doi: 10.3390/cancers13153864 – volume: 81 start-page: 818 year: 2022 end-page: 825 ident: CR25 article-title: PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumor, and other cutaneous sarcomatoid neoplasms: a comparative analysis publication-title: Histopathology doi: 10.1111/his.14797 – volume: 43 start-page: 794 year: 2021 end-page: 800 ident: CR16 article-title: Preferentially expressed antigen in melanoma immunostaining in a series of melanocytic neoplasms publication-title: Am J Dermatopathol doi: 10.1097/dad.0000000000001885 – volume: 47 start-page: 1226 year: 2020 end-page: 1228 ident: CR14 article-title: Diffuse PRAME expression is highly specific for malignant melanoma in the distinction from clear cell sarcoma publication-title: J Cutan Pathol doi: 10.1111/cup.13812 – volume: 49 start-page: 338 year: 2022 end-page: 342 ident: CR22 article-title: PRAME expression in cellular neurothekeoma: a study of 11 cases publication-title: J Cutan Pathol doi: 10.1111/cup.14163 – volume: 1 start-page: 144 year: 2015 end-page: 159 ident: CR30 article-title: Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma publication-title: J Pathol Clin Res doi: 10.1002/cjp2.16 – volume: 6 start-page: 199 year: 1997 end-page: 208 ident: CR1 article-title: Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor publication-title: Immunity doi: 10.1016/s1074-7613(00)80426-4 – volume: 1 start-page: e000068 year: 2016 ident: CR4 article-title: Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study publication-title: ESMO Open doi: 10.1136/esmoopen-2016-000068 – volume: 80 start-page: 384 year: 2021 end-page: 386 ident: CR21 article-title: Preferentially expressed antigen in melanoma (PRAME) expression in malignant, but not benign, peripheral nerve sheath tumors publication-title: J Neuropathol Exp Neurol doi: 10.1093/jnen/nlaa125 – volume: 46 start-page: 579 year: 2022 ident: 3606_CR12 publication-title: Am J Surg Pathol doi: 10.1097/pas.0000000000001878 – volume: 78 start-page: 1000 year: 2021 ident: 3606_CR7 publication-title: Histopathology doi: 10.1111/his.14312 – volume-title: Soft tissue and bone tumours 5th edn year: 2020 ident: 3606_CR23 – volume: 46 start-page: 1467 year: 2022 ident: 3606_CR13 publication-title: Am J Surg Pathol doi: 10.1097/pas.0000000000001944 – volume: 50 start-page: 25 year: 2011 ident: 3606_CR29 publication-title: Genes Chromosom Cancer doi: 10.1002/gcc.20827 – volume: 11 start-page: 2208 year: 2016 ident: 3606_CR5 publication-title: J Thorac Oncol doi: 10.1016/j.jtho.2016.08.1206 – volume: 135 start-page: 541 year: 2017 ident: 3606_CR6 publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2017.0729 – volume: 61 start-page: 130 year: 2017 ident: 3606_CR26 publication-title: Hum Pathol doi: 10.1016/j.humpath.2016.12.006 – volume: 11 start-page: 675296 year: 2021 ident: 3606_CR17 publication-title: Front Oncol doi: 10.3389/fonc.2021.675296 – volume: 13 start-page: 3864 year: 2021 ident: 3606_CR18 publication-title: Cancers doi: 10.3390/cancers13153864 – volume: 80 start-page: 384 year: 2021 ident: 3606_CR21 publication-title: J Neuropathol Exp Neurol doi: 10.1093/jnen/nlaa125 – volume: 44 start-page: 575 year: 2022 ident: 3606_CR19 publication-title: Am J Dermatopathol doi: 10.1097/dad.0000000000002208 – volume: 48 start-page: 479 year: 2021 ident: 3606_CR11 publication-title: J Cutan Pathol doi: 10.1111/cup.13876 – volume: 1 start-page: 144 year: 2015 ident: 3606_CR30 publication-title: J Pathol Clin Res doi: 10.1002/cjp2.16 – volume: 1 start-page: e000068 year: 2016 ident: 3606_CR4 publication-title: ESMO Open doi: 10.1136/esmoopen-2016-000068 – volume: 14 start-page: 165 year: 2021 ident: 3606_CR10 publication-title: Surg Pathol Clin doi: 10.1016/j.path.2021.01.001 – volume: 48 start-page: 1115 year: 2021 ident: 3606_CR8 publication-title: J Cutan Pathol doi: 10.1111/cup.14000 – volume: 43 start-page: 794 year: 2021 ident: 3606_CR16 publication-title: Am J Dermatopathol doi: 10.1097/dad.0000000000001885 – volume: 47 start-page: 1226 year: 2020 ident: 3606_CR14 publication-title: J Cutan Pathol doi: 10.1111/cup.13812 – volume: 82 start-page: 285 year: 2023 ident: 3606_CR15 publication-title: Histopathology doi: 10.1111/his.14814 – volume: 44 start-page: 503 year: 2020 ident: 3606_CR9 publication-title: Am J Surg Pathol doi: 10.1097/pas.0000000000001393 – volume: 29 start-page: 826 year: 2021 ident: 3606_CR27 publication-title: Int J Surg Pathol doi: 10.1177/10668969211012085 – volume: 81 start-page: 818 year: 2022 ident: 3606_CR25 publication-title: Histopathology doi: 10.1111/his.14797 – volume: 45 start-page: 240 year: 2021 ident: 3606_CR20 publication-title: Am J Surg Pathol doi: 10.1097/PAS.0000000000001645 – volume: 49 start-page: 338 year: 2022 ident: 3606_CR22 publication-title: J Cutan Pathol doi: 10.1111/cup.14163 – volume: 12 start-page: 3612 year: 2020 ident: 3606_CR24 publication-title: Cancers doi: 10.3390/cancers12123612 – volume: 6 start-page: 199 year: 1997 ident: 3606_CR1 publication-title: Immunity doi: 10.1016/s1074-7613(00)80426-4 – volume: 122 start-page: 835 year: 2005 ident: 3606_CR2 publication-title: Cell doi: 10.1016/j.cell.2005.07.003 – volume: 114 start-page: 3299 year: 2009 ident: 3606_CR3 publication-title: Blood doi: 10.1182/blood-2008-07-170282 – volume: 54 start-page: 463 year: 2015 ident: 3606_CR28 publication-title: Genes Chromosom Cancer doi: 10.1002/gcc.22254 |
| SSID | ssj0021816 |
| Score | 2.464075 |
| Snippet | Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry is currently used in pathology for the assessment of melanocytic neoplasms; however,... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 145 |
| SubjectTerms | Adult Alveoli Antigens Antigens, Neoplasm Biomarkers, Tumor - metabolism Chondrosarcoma Dermatofibrosarcoma protuberans Diagnosis, Differential Diagnostic software DNA Helicases Ewing's sarcoma Ewings sarcoma Extraskeletal myxoid chondrosarcoma Fasciitis Fibrosarcoma - diagnosis Head & neck cancer Hemangioma Histiocytoma Humans Hyperplasia Immunohistochemistry Inflammation Lesions Lipoma Liposarcoma Lymphangioma Malignancy Medical diagnosis Medicine Medicine & Public Health Melanoma Melanoma - pathology Neoplasms Nuclear Proteins Original Article Pathology Peripheral nerves Rhabdomyosarcoma Sarcoma Sarcoma - diagnosis Sarcoma - pathology Sarcoma, Ewing - diagnosis Schwann cells Sheaths Skin Neoplasms - pathology Soft Tissue Neoplasms - diagnosis Soft Tissue Neoplasms - pathology Soft tissues Synovial sarcoma Thorax Tissues Transcription Factors Tumors |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagIMSFd2GhoEHiBhbJ2k5iLqhCrTjQaoUA9RbZji1FyibLJqnUX8TfZOx1UlBFLxwjJ46TGc_M53kR8sZabWQhNbVCaMpTnlKpdEYL7VKFBr1QoVzTjy_56WlxdiZX8cCtj2GVk0wMgrrqjD8jf49i1AtTWYiPm5_Ud43y3tXYQuMmueWrJLAQureaARdqr-CrlFzQDBVlTJoJqXMBLFDUWBRlOKLq7G_FdMXavOIpDQro-P7_Lv0BuRdNTzjc8cpDcsO2j8idk-hcf0x-rb4enhxB7TNGulCH2Ezd4KBuoUeBDUOgEwzjutv2oNoK1vW6Nv0HUBAq1ULngIkEDGrHHnwx5MbDf_wiqIceJ9_YrY8gAZ_i6cOUEAWAHgfYdIMPXFJNcwFjb93YQLULA8Tlwp9-9ifk-_HRt0-faezjQA3LxUALw5aJ5spwI9DCSbhRHK1Oi6ZfjtaqKjLtrMsKlS9xSFVGOsW4zFVqBKL3iu2TvbZr7TMCUidVYjLrGP5U7-LjGi8rxGFMOVm4BUknIpYmFjn3vTaaci7PHAhfIuHLQPgyW5C38zObXYmPa-8-mIhcxu3el5cUXpDX8zBSyHtfVGu7Mdzj0XUucIqnO56aX8cQ1OWolhbk3cRkl5P_ey3Pr1_LC3J3GRjchysekL1hO9qX5LY5R17Zvgpb5TcIaBrX priority: 102 providerName: ProQuest |
| Title | PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications |
| URI | https://link.springer.com/article/10.1007/s00428-023-03606-6 https://www.ncbi.nlm.nih.gov/pubmed/37477762 https://www.proquest.com/docview/2848012985 https://www.proquest.com/docview/2841022756 |
| Volume | 483 |
| WOSCitedRecordID | wos001034307500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLink customDbUrl: eissn: 1432-2307 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021816 issn: 0945-6317 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_enYgvfp-unssIvmmg3SZt4tspe_jgLcuqy76VJE2h0G2XbSvcX3T_ppNsW5VTQV8KJWk6MJP8fsN8hJDX1mojhdTUcq4pC1lIpdIxFToPFRJ6rny7pvWnZLEQm41c9kVhzZDtPoQk_Uk9Frt5ek8RYyieuugHx0fkBOFOuO24-rwe3SzELB-hlIzTGOGxL5X5_Rq_wtENjnkjPuph5-L-_wn8gNzraSacH-ziIbllq0fkzmUfSH9Mrper88s5FK46pPY9h81w8xsUFTR4OEPrdQJtt633Dagqg22xLUzzDhT4rrRQ5xDxAAwiYQOu8XHpXH2UEYq2wcV3du-yRcCVc7qUJGT8oLsWdnXrkpRUWV5B19i8KyE7pPyhuPBzTP0J-Xox__LhI-3vbKAmSnhLhYlmgWbKMMORzQTMKIYM0yLNS5CZKhHr3OaxUMkMh1RmZK4iJhMVGo6eehadkuOqruwzAlIHWWBim0cIoS6cxzS-ZuhzRSqXIp-QcFBdavqG5u5ejTIdWzF7DaSogdRrII0n5M34ze7QzuOvs88Gi0j7rd2kKIxDdSn4hLwah1FDLtKiKlt3fo7zpBOOSzw9WNL4uwgduAQhaELeDmbzY_E_y_L836a_IHdn3vJcquIZOW73nX1JbptvaDv7KTlKVmv33CT-Kabk5P18sVxNXe7rcuo31HevjRYV |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQZQL78JCgUGCE1jk5SRGQqiCVq26u6qqUvUWbMeRImWTZZOA-ou48RsZO4-CKnrrgeMqideyP88343kR8kprqXjMJdWMSRq4gUu5kCGNZeYKVOiZsOWaTqbRfB6fnvLDNfJryIUxYZWDTLSCOq2UuSN_h2LUCFMes4_Lb9R0jTLe1aGFRgeLA332A022-sP-Z9zf1563u3P8aY_2XQWo8iPW0Fj5niMDoQLFkG-dQIkAdSCNikiEupOIQ5npLIxF5OEjkSqeCT_gkXAVQ1sy9XHca-Q6ynHXhJBFRyejgYdsaX2jPGA0RGLuk3Rsqp41TigyJEXOQCs-_JsIL2i3FzyzlvB27_xvS3WX3O5Va9juzsI9sqbL--TmrA8eeEB-Hh5tz3YgNxkxla2zrIZud5CXUCMhQWNxCE27qFY1iDKFRb7IVf0eBNhKvFBl4DMHFLJ_DabYc2GuN3AFIW9qHHypVyZCBkwKqwnDQisHZNvAsmpMYJYoijNoa521BaRdmCNOF_6MI3hIvlzJMm2S9bIq9WMCXDqpo0Kd-biJxoUZSPyZop3pi4zH2YS4A2gS1RdxN71EimQsP22BliDQEgu0JJyQN-M3y66EyaVvbw2gSnpxVifniJqQl-Nj3CHjXRKlrlr7jrk9iBgO8ajD8Ph3PhqtEdLuhLwdQH0--L_n8uTyubwgG3vHs2ky3Z8fPCW3PHu4TGjmFllvVq1-Rm6o74ib1XN7TIF8vWqw_wY00Hd3 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgiouvB8LBQYJTmA178RICFW0K6q2qxUC1FuwHUeKtJssmwTUX8R_4Ncxdh4FVfTWA8dVEq9lf56H55sZgBdaS8UTLpkOQ8kCN3AZFzJiicxdQQZ9KGy5pi9H8WyWnJzw-Qb8GnJhDK1ykIlWUGeVMnfkOyRGjTDlSbiT97SI-d703eobMx2kTKR1aKfRQeRQn_4g961-e7BHe_3S86b7n95_YH2HAab8OGxYonzPkYFQgQpJ9zqBEgHZQ5qMkpjsKJFEMtd5lIjYo0ciUzwXfsBj4aqQ_MrMp3GvwNXYFC23tMH56OyR5rRxUh6ELCIl3Sfs2LQ966gw0paM9Ad59NHfSvGcpXsuSmuV3_Tm_7xst-BGb3LjbndGbsOGLu_A1nFPKrgLP-cfd4_3sTCZMpWtv6yGLnhYlFiTosLG4hObdlmtaxRlhstiWaj6DQq0FXqxytEPHVRkFdRoikAvzLUHrSYWTU2Dr_TaMGfQpLYaehZ5PyjbBldVYwhbYrE4xbbWtHyYdfRHmi7-yS-4B58vZZnuw2ZZlfohIJdO5qhI5z5tqAltBpJ-ZuR_-iLnST4BdwBQqvri7qbHyCIdy1Jb0KUEutSCLo0m8Gr8ZtWVNrnw7e0BYGkv5ur0DF0TeD4-ph0yUSdR6qq175hbhTikIR50eB7_zidnNiZ1PIHXA8DPBv_3XB5dPJdnsEUYT48OZoeP4bpnz5lhbG7DZrNu9RO4pr4TbNZP7YlF-HrZWP8N1SGAGQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PRAME+immunohistochemistry+in+soft+tissue+tumors+and+mimics%3A+a+study+of+350+cases+highlighting+its+imperfect+specificity+but+potentially+useful+diagnostic+applications&rft.jtitle=Virchows+Archiv+%3A+an+international+journal+of+pathology&rft.au=Cammareri%2C+Chlo%C3%A9&rft.au=Beltzung%2C+Fanny&rft.au=Michal%2C+Michael&rft.au=Vanhersecke%2C+Lucile&rft.date=2023-08-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0945-6317&rft.eissn=1432-2307&rft.volume=483&rft.issue=2&rft.spage=145&rft.epage=156&rft_id=info:doi/10.1007%2Fs00428-023-03606-6&rft.externalDocID=10_1007_s00428_023_03606_6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0945-6317&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0945-6317&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0945-6317&client=summon |